about
Symptoms, ultrasound imaging and biochemical markers alone or in combination for the diagnosis of ovarian cancer in women with symptoms suspicious of ovarian cancerClinical relevance of circulating cell-free microRNAs in ovarian cancerHallmarks of glycosylation in cancerCancer screening in the United States, 2016: A review of current American Cancer Society guidelines and current issues in cancer screeningCancer screening in the United States, 2013: a review of current American Cancer Society guidelines, current issues in cancer screening, and new guidance on cervical cancer screening and lung cancer screeningCancer screening in the United States, 2015: a review of current American cancer society guidelines and current issues in cancer screeningCancer screening in the United States, 2014: a review of current American Cancer Society guidelines and current issues in cancer screeningSafety and Outcome Measures of First-in-Human Intraperitoneal α Radioimmunotherapy With 212Pb-TCMC-Trastuzumab.A robust biomarker discovery pipeline for high-performance mass spectrometry data.The Extracellular Matrix in Epithelial Ovarian Cancer - A Piece of a Puzzle.Sweetening the pot: adding glycosylation to the biomarker discovery equationPeritoneal inclusion cysts in pregnancy, a diagnostic challenge.Texture analysis applied to second harmonic generation image data for ovarian cancer classification.Abnormal CA-125 levels in menopausal women without ovarian cancerPeritoneal tuberculosis mimicking advanced ovarian carcinoma: an important differential diagnosis to consider.Diagnostic Difficulties in Woman with Crohn's Disease, Ascites, and Elevated Value of Serum CA125 AntigenPlasma miRNAs as diagnostic and prognostic biomarkers for ovarian cancer.A lectin affinity workflow targeting glycosite-specific, cancer-related carbohydrate structures in trypsin-digested human plasma.A xenograft mouse model coupled with in-depth plasma proteome analysis facilitates identification of novel serum biomarkers for human ovarian cancerDose escalation and dosimetry of first-in-human α radioimmunotherapy with 212Pb-TCMC-trastuzumab.Extremely elevated CA-125 in benign ovarian disease due to stretch of the peritoneumLectin chromatography/mass spectrometry discovery workflow identifies putative biomarkers of aggressive breast cancers.Simultaneous predictive value of NT-proBNP and CA-125 in patients newly diagnosed with advanced heart failure: preliminary resultsENOX2-based early detection (ONCOblot) of asbestos-induced malignant mesothelioma 4-10 years in advance of clinical symptoms.Plasma microRNAs as novel biomarkers for endometriosis and endometriosis-associated ovarian cancerProfiling of serum and tissue high abundance acute-phase proteins of patients with epithelial and germ line ovarian carcinomaQuantification of Somatic Chromosomal Rearrangements in Circulating Cell-Free DNA from Ovarian Cancers.State of the art in tumor antigen and biomarker discovery.Protein isoform-specific validation defines multiple chloride intracellular channel and tropomyosin isoforms as serological biomarkers of ovarian cancer.Commentary: Diagnosing ovarian cancer--more problems than answers.Bead-based ELISA for validation of ovarian cancer early detection markersPeritoneal tuberculosis with elevated CA-125 mimicking ovarian cancer with carcinomatosis peritonei: Crucial CT findings.Molecular signatures of ovarian cancer: from detection to prognosis.Investigation on tissue specific effects of pro-apoptotic micro RNAs revealed miR-147b as a potential biomarker in ovarian cancer prognosis.Cancer screening in the United States, 2011: A review of current American Cancer Society guidelines and issues in cancer screening.Highly glycosylated tumour antigens: interactions with the immune system.Cancer screening in the United States, 2012: A review of current American Cancer Society guidelines and current issues in cancer screening.Ovarian cancer: biomarker proteomic diagnosis in progress.Pseudo-pseudo Meigs' syndrome in a patient with systemic lupus erythematosus.Ovarian cancer evolution through stochastic genome alterations: defining the genomic role in ovarian cancer.
P2860
Q24187351-0854CB8F-DCD8-4FDE-A068-3B62F3D415C6Q26747154-78B36F86-6A85-4738-AE68-0130ADAFCBD0Q26752363-9387D418-8C83-4235-95BB-B317B5C15688Q26770123-2F6C13D1-3731-4668-B682-E6551A68EF09Q26864419-D8EC4AB1-0C92-436F-88C8-690AE1D9A7ABQ27001043-68FCC9AD-6E27-48D0-8245-620BE83EDB3FQ27025805-019A8D67-6ECE-42B4-9759-65FFA5AAFCB5Q30490448-DF68AF59-1820-4893-B128-67325FB6DC73Q33302448-301F844E-0541-430F-8945-2B48880A0B87Q33361929-27E32FB0-DC75-40A1-9180-61D415E977CBQ33768460-DF7A43DF-422C-4EF5-B6E7-0BB6482D2C37Q33802378-C9474FBA-A3F2-4438-A4A8-45012106F158Q34168221-DFCD8AA8-1EAE-41B6-8AB2-1910F10E44A2Q34598407-201C584A-0A77-45A5-8FDB-17F2F0E6BC30Q34627830-6C3D5ADF-5A6B-4C7F-82C1-E0352B4F36A2Q34651710-D802371E-8273-4E7E-92F6-18C0AD2D6789Q35040690-28A9FC34-720A-4F92-8712-1E171017E5F1Q35499086-CE8A9E47-8ABB-4C72-B81D-4D58429FA549Q35736782-FAF307BD-E9D9-4875-A7B4-6C5B9E6B167DQ35800092-F50E1D0D-496F-4CD1-9CD9-DCB85FDFA48DQ35978597-98247FAA-EBF5-4D10-9442-78B790AF523BQ36058024-27509889-A302-42C0-9AF8-ECB89B729BBBQ36286287-1B4D9E4D-12BD-405D-A6AF-5C7B9442C03FQ36493568-3BED19C1-0948-4845-B762-D73892881F0AQ36679982-907F50C0-C33D-4F30-87BF-0D1017C2A664Q36812596-671DBF55-10D9-41A6-801A-06004A6A9C6CQ37110941-13F0F438-A0CB-4185-BB4C-A49A66A4AEBFQ37132800-D63E25C7-0737-4D91-8D66-CAC719BCC851Q37187957-DAE15D0B-974B-4620-816C-8963E4C13EB3Q37318288-70B43137-5BBE-4615-A64C-9BDC3BE59EC1Q37324630-86BAAB6F-D246-4684-9665-4F60AD8660AEQ37654602-0776083B-B952-40FC-8380-85017F7F28AFQ37685074-E264A938-CDEE-45AD-9F68-8EC3ABBDC75FQ37745830-2D408507-0B8C-473E-8581-267C22F08DB4Q37826011-D3B15482-BC0B-4D19-A366-A7BE42F1628BQ37832274-F346CF7E-8961-49B1-AFFF-A52DFB2A98ECQ37977324-28AC78FA-9C6C-46AE-929C-75EA969399D1Q38040333-157E1D75-E3A3-47AE-82B6-BC704C08588AQ38043948-2DCFEA5B-5524-4FD2-AEA1-D93F191AE40CQ38154665-64694FD8-C7B2-48E6-B8FE-4FA05B114A47
P2860
description
2005 nî lūn-bûn
@nan
2005 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի մարտին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
The role of CA125 in clinical practice
@ast
The role of CA125 in clinical practice
@en
The role of CA125 in clinical practice
@nl
type
label
The role of CA125 in clinical practice
@ast
The role of CA125 in clinical practice
@en
The role of CA125 in clinical practice
@nl
prefLabel
The role of CA125 in clinical practice
@ast
The role of CA125 in clinical practice
@en
The role of CA125 in clinical practice
@nl
P2860
P3181
P356
P1476
The role of CA125 in clinical practice
@en
P2093
J Hollingworth
T M Reynolds
P2860
P304
P3181
P356
10.1136/JCP.2004.018077
P407
P577
2005-03-01T00:00:00Z